Is it Possible to Predict High-Risk Patients in Acute Pulmonary Embolism with Systemic Immune-Inflammation Index?
Eurasian Journal of Critical Care · 2022
DOI: 10.55994/ejcc.1193320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Critical Care, 2022. Verfasst von Murat DUYAN und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: The authors declare no conflict of interest or any financial support..
Abstract (Originalsprache)
Background
Acute pulmonary embolism (APE) is a cardiovascular emergency that has a high morbidity and mortality probability. The aim of this study is to investigate the clinical value of the systemic immune inflammation index (SII) in predicting high-risk patients admitted to the emergency department with a diagnosis of Acute pulmonary embolism (APE). Materials and Methods: This clinical study, which was conducted according to a cross-sectional study design, included 193 patients diagnosed with APE who presented to the emergency department of a tertiary hospital. According to the guideline, patients with Pulmonary Embolism Severity Index (PESI) class III–V or sPESI ≥I were identified as high risk. ROC (Area Under the Curve) analysis was used to determine the cut-off in predicting high-risk APE.
Results
In our research, 71 of the patients had high-risk APE. In detecting high-risk APE, SII was found to have excellent diagnostic power (AUC: 0.84), while neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and monocyte to lymphocyte (MLR) were found to have acceptable diagnostic power (AUC: 0.76-0.78), red cell distribution width (RDW) to lymphocyte (RLR) was of fair diagnostic power (AUC: 0.68).
Conclusion
We have shown that SII can be a valuable and useful potential biomarker to identify high-risk patients in patients with APE. We also found that MLR and RLR are biomarkers that can be used to predict severe APE.
Förderung
- The authors declare no conflict of interest or any financial support.
Zitieren
APA
DUYAN, M., SARIDAŞ, A., & VURAL, N. (2022). Is it Possible to Predict High-Risk Patients in Acute Pulmonary Embolism with Systemic Immune-Inflammation Index?. Eurasian Journal of Critical Care. https://doi.org/10.55994/ejcc.1193320
Vancouver
DUYAN M, SARIDAŞ A, VURAL N. Is it Possible to Predict High-Risk Patients in Acute Pulmonary Embolism with Systemic Immune-Inflammation Index?. Eurasian Journal of Critical Care. 2022. doi:10.55994/ejcc.1193320
BibTeX
@article{DUYAN2022,
author = {DUYAN, Murat and SARIDAŞ, Ali and VURAL, Nafis},
title = {Is it Possible to Predict High-Risk Patients in Acute Pulmonary Embolism with Systemic Immune-Inflammation Index?},
journal = {Eurasian Journal of Critical Care},
year = {2022},
doi = {10.55994/ejcc.1193320}
}
EUVIMED